Research output per year
Research output per year
Unit profile
Research
The department focuses on research that aims to develop gene therapy for hematopoietic cells using viral vectors. Hematopoiesis, in particular the genetic control of hematopoietic cell proliferation and differentiation is also studied in human cell cultures and transgenic mouse model systems.Description
Dysfunctional blood cell development can have fatal consequences on human health, with implications for several key areas of modern medicine, including amongst others the broad research areas of oncology and immunology. The Division of Molecular Hematology (DMH) aims to generate new knowledge about the regulation of blood cell development by applying recent advances in stem cell technology, in order to dissect the molecular regulation of hematopoiesis. Our mission is to translate this information into clinical contexts to advance the full potential of regenerative medicine.Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Units
-
Cell Reprogramming in Hematopoiesis and Immunity
Division of Molecular Medicine and Gene Therapy
Organisational unit: Research group
-
Hematopoiesis and Gene Therapy
Division of Molecular Medicine and Gene Therapy
Organisational unit: Research group
-
Hematopoietic Stem Cell Development
Division of Molecular Medicine and Gene Therapy
Organisational unit: Research group
Profiles
-
Abdul Ghani Alattar
- Division of Molecular Medicine and Gene Therapy - Research engineer
- Stem Cells to Red Blood Cells - Research engineer
- Transfusion Medicine - Research engineer
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Research engineer
- LUCC: Lund University Cancer Centre - Research support
Person
-
Abigail Altman
- Division of Molecular Medicine and Gene Therapy - Student working on a degree project
- Cell Reprogramming in Hematopoiesis and Immunity - Student working on a degree project
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Doctoral student
- LUCC: Lund University Cancer Centre - Doctoral student
Person
-
Rita Alves
- Cell Reprogramming in Hematopoiesis and Immunity - Doctoral student
- Division of Molecular Medicine and Gene Therapy - Doctoral student
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Doctoral student
- LUCC: Lund University Cancer Centre - Doctoral student
Person
Research output
-
Assessing efficacy and immune-stimulatory effects of tumor-derived dendritic cell reprogramming using immuno-competent 3D tumor spheroid model
Agarkova, I., Rotankova, N., Rudnik, M., Strebel, S., Zimmermannova, O., Rosa, A., Fiúza Rosa, F., Moritz, W., Pereira, C-F. & Pires, C., 2023 Apr 4, In: Cancer Research. 83, 7 Supplement, 1 p., 4550.Research output: Contribution to journal › Published meeting abstract › peer-review
-
Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia
Canals, I., Comella-Bolla, A., Cepeda-Prado, E., Avaliani, N., Crowe, J. A., Oburoglu, L., Bruzelius, A., King, N., Pajares, M. A., Pérez-Sala, D., Heuer, A., Rylander Ottosson, D., Soriano, J. & Ahlenius, H., 2023, In: Brain Communications. 5, 3, p. 1-16 fcad158.Research output: Contribution to journal › Article › peer-review
Open Access -
Best Practices to Promote Data Utility and Reuse by the Non-Traditional Model Organism Community
Dunlap, G. S. & Leigh, N. D., 2023, In: Methods in molecular biology (Clifton, N.J.). 2562, p. 461-469 9 p.Research output: Contribution to journal › Article
-
Investigation into the adaptive immune system in Pleurodeles waltl
2023/04/11 → …
Project: Dissertation
-
Neoantigen Identification with Dendritic Cell Reprogramming
Pereira, F., Ascic, E., Nascimento Caiado, I. M., Kurochkin, I., Fiúza Rosa, F., Pires, C., Bassani, M., Marie Svane, I. & Greiff, L.
2023/01/01 → …
Project: Research
-
REPROcode: a single-cell platform to define transcription factors for immune cell reprogramming
Pereira, F., Kurochkin, I., Altman, A., Nascimento Caiado, I. M., Pértiga Cabral, D. F., Nair, M. S., Zimmermannova, O., Fiúza Rosa, F. & Pires, C.
2023/01/01 → …
Project: Research
Activities
-
Harnessing Direct Cellular Reprogramming for Cancer Immunotherapy
Filipe Pereira (Invited speaker)
2023 Jun 1Activity: Talk or presentation › Invited talk
-
6th Swedish Cancer Research Meeting
Göran B Jönsson (Keynote/plenary speaker), Thoas Fioretos (Keynote/plenary speaker), Sophia Zackrisson (Chair), Yvonne Ceder (Chair), Evangelia Sereti (Session chair), Kajsa Paulsson (Speaker), Anna Sandström Gerdtsson (Speaker), Alexander Pietras (Speaker), Sophie Lehn (Session chair), Ervin Ascic (Speaker), Johann de Bono (Keynote/plenary speaker), Daniel Öhlund (Keynote/plenary speaker), luiz diaz (Keynote/plenary speaker), Anna Martner (Keynote/plenary speaker), Gunilla Enblad (Keynote/plenary speaker), Laura J. Esserman (Keynote/plenary speaker), Olli Kallioniemi (Keynote/plenary speaker) & Regina Beets-Tan (Keynote/plenary speaker)
2023 May 16 → 2023 May 17Activity: Participating in or organising an event › Organisation of conference
File -
Harnessing Cellular Reprogramming for Cancer Immunotherapy
Filipe Pereira (Invited speaker)
2023Activity: Talk or presentation › Invited talk
Prizes and distinction
-
ERC Proof of Concept Grant
Pereira, Filipe (Recipient), 2023
Prize: Prize (including medals and awards)
-
Novo Nordisk Distinguished Innovator Grant
Pereira, Filipe (Recipient), 2023
Prize: Prize (including medals and awards)
-
WCMM Research School Grant Award
Ascic, Ervin (Recipient), 2022 Jun 8
Prize: Prize (including medals and awards)